Skip to main content
. 2020 Mar 17;11:124. doi: 10.1186/s13287-020-01636-4

Table 3.

Patients with AEs up to month 12 (safety population)

AE Observation group (n = 11) Control group (n = 11)
Overall 7 (63.6%) 11 (100%)
AEs
Pyrexia 3 (27.3%) 4 (36.4%)
Perianal pain 7 (63.6%) 11 (100%)
Anal abscess/fistula 3 (27.3%) 5 (45.5%)
Fatigue 4 (36.4%) 8 (72.7%)
AEs leading to study withdrawal 2 (18.2%) 3 (27.3%)
Treatment-related AEs 0 (0%) 11 (100%)
Perianal pain 0 (0%) 11 (100%)
Anal abscess/fistula 0 (0%) 1 (9.1%)
Serious AEs 0 (0%) 0 (0%)